Treatment of multiple sclerosis, including anti-CD20 antibodies for patients under 55 years of age and/or infected with lymph nodes and/or at least one EDSS point and/or more than five MSS scores; diagnostic methods And product manufacturing.

摘要

Progressive multiple sclerosis treatment, including anti-CD20 antibody for patients under 55 years old and / or injured patients with lymphocytes and / or at least one point of increase and / or MSS score more than 5 points; diagnostic methods; and manufactured products.